Country for PR: United States
Contributor: PR Newswire New York
Friday, November 05 2021 - 00:30
AsiaNet
Associates of Cape Cod Inc. Announces the Release of its One Millionth Horseshoe Crab From its Species Sustainability Project
E. FALMOUTH, Mass., Nov. 5, 2021 /PRNewswire-AsiaNet/ --

ACC proudly announces that it has achieved the release of its millionth 
juvenile horseshoe crab to the wild, as a result of its species sustainability 
project. The program is the first of its kind to release ecologically 
significant numbers of North American Horseshoe Crabs (NAHSC); it was initiated 
by the company in 2017 in the US and expanded into Asia in 2019, with a goal of 
enhancing the sustainability of crab populations that are so vital to local 
ecosystems as well as to the manufacture of Bacterial Endotoxin Test (BET) 
reagents that utilize a raw material found in crab blood. ACC's reagents are 
used worldwide in pharmaceutical, medical device, biotechnology, compounding 
pharmacy and dialysis industries for quality control, product release and 
research. 

Video - https://www.youtube.com/watch?v=W36W2HxKT8I 

Logo - 
https://mma.prnewswire.com/media/1223081/Associates_of_Cape_Cod_Inc_Logo.jpg 

With the goal of maintaining the greatest biodiversity possible, ACC's species 
sustainability project sources NAHSC eggs and gametes exclusively from crabs 
destined for terminal use as bait by the fishing industry. Without injury to 
the crab, ACC staff harvest the reproductive cells, fertilize them in vitro and 
then culture them to juvenile horseshoe crabs all within ACC's innovative, 
patent pending aquaculture system at its facility in Falmouth, MA. Once the 
crabs reach their first and second instars (about the size of a small 
fingernail) the juveniles are released into the wild in a setting where they 
can immediately burrow to safety.

"Our horseshoe crab sustainability project is important to the company and 
other stakeholders of effected ecosystems," noted Dr. A.J. Meuse, President and 
CEO of ACC, "This project aligns closely with our overall plans to minimize our 
impact on the populations of the NAHSC and provided an opportunity to develop a 
completely new aquaculture system technology specifically designed to support 
the growth of horseshoe crabs. Local regulators supported our mission and 
granted ACC a class 1 type 4 aquaculture permit that allowed us to make this 
program a reality."

"The raising and releasing of more than a million horseshoe crabs into the 
local ecosystems is expected to continue and have a measurable and positive 
impact on horseshoe crab populations for years to come," said Brett 
Hoffmeister, LAL Production Manager, ACC and author of the patent pending 
aquaculture system. "As team leader, this incredible achievement would not have 
been possible without the hard work and dedication of the ACC employees who 
make up our horseshoe crab species sustainability team.  We're excited to see 
the impact that our program will have on our local aquatic ecosystem and 
appreciate the vision of our corporate ownership who fully support our 
efforts." Mr. Hoffmeister also commented that ACC's decision to provide these 
highly specialized aquaculture systems free of charge to qualified academics in 
Asia to support Tachypleus population recovery shows the company's dedication 
to making a global impact. 

ACC believes its incredibly successful horseshoe crab sustainability project is 
the first to make an impact of this magnitude by any provider of Limulus 
Ameobocyte Lysate (LAL) products. Since 2011, as an organization, ACC has 
demonstrated its commitment to the environment and thoughtful use of resources 
through other operational initiatives such as waste-water reduction and reuse 
programs, packaging recycling practices, and the introduction of 
environmentally friendly water-based glues and vegetable-based inks for 
printing. 

About Associates of Cape Cod Inc. -- A Seikagaku Group Company

Specializing in chromogenic and turbidimetric reagent technologies, Associates 
of Cape Cod, Inc. (ACC) has been a global leader in endotoxin and 
(1,3)-beta-D-glucans detection products and services for nearly 50 years. ACC 
pioneered modern LAL testing methodology and was the first U.S. FDA licensed 
company to manufacture LAL reagents; ACC is today recognized as an 
international leader in endotoxin detection. Visit www.acciusa.com for more 
information.

For further information contact
Vann Jones -- Senior Manager, Marketing
Associates of Cape Cod, Inc.
East Falmouth, MA   02536
USA
Phone: +1-888-395-2221
VJones@acciusa.com
www.acciusa.com

SOURCE Associates of Cape Cod Inc.
Translations

Japanese